Treatment of Adult-onset Still's Disease: a Review

Overview

Journal Ther Clin Risk Manag

Publisher Dove Medical Press

Date 2015 Feb 6

PMID 25653531

Citations 55

Authors

Yvan Jamilloux

Mathieu Gerfaud-Valentin

Thomas Henry

Pascal Seve

Affiliations

Soon will be listed here.

Abstract

Adult-onset Still's disease (AOSD) is a rare inflammatory disorder that has been recently classified as a polygenic autoinflammatory disorder. The former classification, based on the disease course, seems to be quite dated. Indeed, there is accumulating evidence that AOSD can be divided into two distinct phenotypes based on cytokine profile, clinical presentation, and outcome, ie, a "systemic" pattern and an "articular" pattern. The first part of this review deals with the treatments that are currently available for AOSD. We then present the different strategies based on the characteristics of the disease according to clinical presentation. To do so, we focus on the two subsets of the disease. Finally, we discuss the management of life-threatening complications of AOSD, along with the therapeutic options during pregnancy.

Citing Articles

Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease.

Bindoli S, De Matteis A, Mitrovic S, Fautrel B, Carmona L, De Benedetti F Ann Rheum Dis. 2024; 83(12):1731-1747.

PMID: 39317415 PMC: 11671904. DOI: 10.1136/ard-2024-225854.

Cracking the code: high ferritin load with Salmon-Colored skin episodes.

Satyal P, Sukhcharan W, Yakubov N, Babu B Oxf Med Case Reports. 2024; 2024(8):omae092.

PMID: 39184869 PMC: 11343824. DOI: 10.1093/omcr/omae092.

Not All Fevers Equal Infection: A Challenging Case of Adult-Onset Still's Disease.

Ukoha N, Olaosebikan K, Berchie P, Ansari F, Nlandu Z Cureus. 2024; 16(5):e59968.

PMID: 38854353 PMC: 11162284. DOI: 10.7759/cureus.59968.

Pregnancy-Associated Onset of Adult-Onset Still's Disease.

Zayat N, Arora A, OBrien J, Bal J, Sugarman R, Rivera L AJP Rep. 2024; 14(2):e145-e155.

PMID: 38799549 PMC: 11126333. DOI: 10.1055/a-2318-0305.

Association between adult-onset still's disease and COVID-19: A report of two cases and brief review.

Fet-He S, Ibarra Lecompte G, Quiroz Alfaro A SAGE Open Med Case Rep. 2024; 12:2050313X241233197.

PMID: 38404500 PMC: 10893826. DOI: 10.1177/2050313X241233197.

References

Efthimiou P, Kadavath S, Mehta B . Life-threatening complications of adult-onset Still's disease. Clin Rheumatol. 2014; 33(3):305-14. PMC: 7102228. DOI: 10.1007/s10067-014-2487-4. View

Cush J, Medsger Jr T, CHRISTY W, Herbert D, Cooperstein L . Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987; 30(2):186-94. DOI: 10.1002/art.1780300209. View

Nordstrom D, Knight A, Luukkainen R, van Vollenhoven R, Rantalaiho V, Kajalainen A . Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. J Rheumatol. 2012; 39(10):2008-11. DOI: 10.3899/jrheum.111549. View

Kobayashi M, Takahashi Y, Yamashita H, Kaneko H, Mimori A . Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol. 2010; 21(1):92-6. DOI: 10.1007/s10165-010-0348-9. View

Vasques Godinho F, Parreira Santos M, Canas da Silva J . Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis. 2004; 64(4):647-8. PMC: 1755446. DOI: 10.1136/ard.2004.026617. View

Hot A, Toh M, Coppere B, Perard L, Girard Madoux M, Mausservey C . Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore). 2010; 89(1):37-46. DOI: 10.1097/MD.0b013e3181caf100. View

Laskari K, Tzioufas A, Moutsopoulos H . Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther. 2011; 13(3):R91. PMC: 3218906. DOI: 10.1186/ar3366. View

Tristano A . Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Med Sci Monit. 2008; 14(3):RA27-36. View

Yokoyama M, Suwa A, Shinozawa T, Fujii T, Mimori T, Akizuki M . [A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation]. Nihon Rinsho Meneki Gakkai Kaishi. 1995; 18(2):207-14. DOI: 10.2177/jsci.18.207. View

10.

Gerfaud-Valentin M, Seve P, Iwaz J, Gagnard A, Broussolle C, Durieu I . Myocarditis in adult-onset still disease. Medicine (Baltimore). 2014; 93(17):280-289. PMC: 4602418. DOI: 10.1097/MD.0000000000000112. View

11.

Uppal S, Pande I, Kumar A, Kailash S, Sekharan N, Adya C . Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease. Br J Rheumatol. 1995; 34(5):429-34. DOI: 10.1093/rheumatology/34.5.429. View

12.

Swart J, Barug D, Mohlmann M, Wulffraat N . The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis. Expert Opin Biol Ther. 2010; 10(12):1743-52. DOI: 10.1517/14712598.2010.532785. View

13.

Pavy S, Constantin A, Pham T, Gossec L, Maillefert J, Cantagrel A . Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine. 2006; 73(4):388-95. DOI: 10.1016/j.jbspin.2006.01.007. View

14.

Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T . Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010; 49(9):1645-53. DOI: 10.1093/rheumatology/keq133. View

15.

Sari I, Birlik M, Binicier O, Akar S, Yilmaz E, Onen F . A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage. J Korean Med Sci. 2009; 24(1):155-7. PMC: 2650997. DOI: 10.3346/jkms.2009.24.1.155. View

16.

Fautrel B, Borget C, Rozenberg S, Meyer O, Le Loet X, Masson C . Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol. 1999; 26(2):373-8. View

17.

Pouchot J, Sampalis J, Beaudet F, Carette S, Decary F, HILL R . Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991; 70(2):118-36. View

18.

Mitamura M, Tada Y, Koarada S, Inoue H, Suematsu R, Ohta A . Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease. Mod Rheumatol. 2008; 19(1):57-63. DOI: 10.1007/s10165-008-0126-0. View

19.

Maria A, Le Quellec A, Jorgensen C, Touitou I, Riviere S, Guilpain P . Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev. 2014; 13(11):1149-59. DOI: 10.1016/j.autrev.2014.08.032. View

20.

Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I . Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014; 93(2):91-99. PMC: 4616309. DOI: 10.1097/MD.0000000000000021. View